Leflunomide in psoriatic arthritis: A retrospective study of discontinuation rate in daily clinical practice compared with methotrexate

Clinical and Experimental Rheumatology

Volumn 25, Issue 6, 2007, Pages 881-884

  Malesci, Domemco ^a   Tirri, Rosella ^a   Buono, Rosario ^a   La Montagna, Giovanni ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Leflunomide; Methotrexate; Psoriatic arthritis; Safety

Indexed keywords

CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FOLIC ACID; GLUCOCORTICOID; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LEUKOPENIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME;

ADJUVANTS, IMMUNOLOGIC; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 38649136659     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. KALTWASLER JP, BEHRENS F: Leflunomide: long term clinical experience and new uses. Expert Opin Pharmacother 2005; 6: 787-801.
2. STRAND V, COHEN S, SCHIFF M et al.: Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999; 159: 2542-50.
3. KALTWASSER JP, NASH P, GLADMAN D et al.: Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind randomized, placebo-controlled clinical trial. Arthritis Rheum 2004; 50: 1939-50.
4. MARTIN K, BENTABERRY F, DUMOULIN C et al.: Effectiveness and safety profile of leflunomide in rheumatoid arthritis: Actual practice compared with clinical trials. Clin Exp Rheumatol 2005; 23: 80-4.
5. BETTEMBOURG-BRAULT I, GOSSEC L, PHAM T, GOTTENBERG J-E, DAMIANO J, DOUGADOS M: Leflunomide in rheumatoid arthritis in daily clinical practice: Treatment discontinuation rates in comparison with other DMARDs. Clin Exp Rheumatol 2006; 24: 168-71.
6. DOUGADOS M, VAN DER LINDEN S, JUHLIN R et al.: The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991; 34: 1218-27.
7. CANNON GW, HOLDEN WL, JUHAERI J, DAI W, SCARAZZINI L, STANG P: Adverse events with disease modifying antirheumatic drugs (DMARD): A cohort study of leflunomide compared with other DMARD. J Rheumatol 2004; 31: 1906-11.
8. COHEN S, CANNON GW, SCHIFF M et al.: Two-years, blinded, randomized, controlled trial of treatment of active rehumatoid arthritis with leflunoimide compared with methotrexate. Utilization of lefltmomide in the treatment of rheumatoid arthritis trial investigator group. Arthritis Rheum 2001; 44: 1984-92.
9. EMERY P, BREEDVELD FC, LEMMEL EM et al.: A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology 2000; 39: 655-65.
10. SORIANO ER, MCHUGH N: Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 2006; 33: 1422-30.
11. WILLKENS RF, WILLIAMS HJ, WARD JR et al.: Randomized, double blind, placebo-controlled trial of low- dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984; 27: 376-81.
12. SPADARO A, RICCIERI V, SILI-SCAVALLI A, SENSI F, TACCARI E, ZOPPINI A: Comparison of cyclosporine A and methotrexate in the treatment of psoriatic arthritis: A one-year prospective study. Clin Exp Rheumatol 1995; 13: 589-93.
13. WHITING-O'KEEFE QE, FYE FH, SACK KD: Methotrexate and histological hepatic abnormalities: A meta-analysis. Am J Med 1991; 90: 711-6.
14. GRASSI W, DE ANGELIS R, CERVINI C: Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis patients. Clin Rheumatol 1998; 17: 223-6.